measles
Information
- Disease name
- measles
- Disease ID
- DOID:8622
- Description
- "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Measles virus, which is transmitted_by contact with oronasal secretions, or semen of an infected person. The infection has_symptom fever, has_symptom cough, has_symptom coryza, has_symptom conjunctivitis, and has_symptom maculopapular, erythematous rash." [url:http\://en.wikipedia.org/wiki/Measles]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00384397 | Completed | Phase 3 | A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers | September 2006 | February 2009 |
| NCT00013871 | Completed | N/A | Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs | November 2004 | |
| NCT00092391 | Completed | Phase 3 | A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) | February 1999 | July 2001 |
| NCT00092404 | Completed | Phase 2 | Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) | December 2001 | June 2005 |
| NCT00092430 | Completed | Phase 3 | Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) | September 26, 2002 | June 9, 2003 |
| NCT00109278 | Completed | Phase 2 | A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED) | October 2004 | May 2005 |
| NCT00109343 | Completed | Phase 3 | V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) | March 2006 | September 2007 |
| NCT00126997 | Completed | Phase 4 | Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | May 2005 | November 2005 |
| NCT00127010 | Completed | Phase 3 | Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | November 2005 | June 2006 |
| NCT00127023 | Completed | Phase 3 | Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | May 2005 | November 2005 |
| NCT01681992 | Completed | Phase 3 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life | October 10, 2012 | August 18, 2015 |
| NCT01702428 | Completed | Phase 3 | Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age | November 9, 2012 | April 16, 2015 |
| NCT01777529 | Completed | Phase 4 | Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations | October 2012 | December 2013 |
| NCT01874457 | Completed | Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella) | May 2008 | August 2009 | |
| NCT01878435 | Completed | N/A | Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya | October 2013 | February 2016 |
| NCT01991899 | Completed | Phase 3 | Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. | February 2015 | July 2016 |
| NCT02058563 | Completed | Phase 3 | Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older | July 1, 2014 | September 17, 2015 |
| NCT02058927 | Completed | Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia | May 2011 | February 2012 | |
| NCT02196285 | Completed | Phase 1 | Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella | September 2015 | March 2016 |
| NCT02325310 | Completed | Phase 4 | Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR | February 4, 2015 | November 1, 2017 |
| NCT02643433 | Completed | Phase 4 | Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines | August 2015 | June 2016 |
| NCT02880865 | Completed | Phase 4 | Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine | October 13, 2016 | July 11, 2017 |
| NCT02904642 | Completed | N/A | Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial | December 6, 2016 | April 4, 2017 |
| NCT03071575 | Completed | Phase 4 | Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age | March 9, 2017 | March 18, 2018 |
| NCT03148990 | Completed | Phase 2/Phase 3 | Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella | November 20, 2018 | August 12, 2020 |
| NCT03160820 | Completed | Phase 4 | Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine | March 2016 | February 2017 |
| NCT03870061 | Completed | N/A | Evaluation of an Infant Immunization Encouragement Program in Nigeria | July 1, 2018 | February 20, 2020 |
| NCT04013516 | Completed | N/A | Measles Vaccination Cash Incentives Experimental Evidence From Nigeria | May 12, 2017 | September 11, 2017 |
| NCT04177485 | Completed | N/A | Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda | February 1, 2016 | December 4, 2017 |
| NCT04183114 | Completed | Phase 2/Phase 3 | Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study) | September 3, 2019 | November 11, 2019 |
| NCT04394689 | Completed | Phase 1/Phase 2 | Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial | May 19, 2021 | December 31, 2022 |
| NCT05592756 | Completed | Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed | April 6, 2020 | March 31, 2022 | |
| NCT05614791 | Completed | Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience | January 1, 2019 | May 30, 2020 | |
| NCT00168532 | Completed | Phase 3 | Prophylactic Antibiotics in Measles | January 1998 | October 2001 |
| NCT00168545 | Completed | Phase 4 | Immunology of Non-specific Effects of Vaccine | January 2006 | January 2007 |
| NCT00168558 | Completed | Phase 4 | Early Two-dose Measles Vaccination Trial | July 2003 | March 2008 |
| NCT00168571 | Completed | Phase 4 | Long-term Follow-up of Measles Antibodies | March 2002 | January 2007 |
| NCT00168662 | Completed | Phase 4 | Non-Specific Effects of Standard Titre Measles Vaccination | March 1995 | January 2006 |
| NCT00240916 | Completed | Ontogeny of Measles Immunity in Infants | July 1993 | July 2013 | |
| NCT00247091 | Completed | Impact of HIV on Measles and Measles Immunisation | May 2000 | September 2004 | |
| NCT00313950 | Completed | Phase 4 | Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine | September 2006 | April 2010 |
| NCT00326183 | Completed | Phase 4 | Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) | March 26, 2007 | January 15, 2008 |
| NCT00351923 | Completed | Phase 3 | Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes | March 2006 | December 2006 |
| NCT00352898 | Completed | Phase 2 | Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ | April 2006 | November 2006 |
| NCT00353288 | Completed | Phase 2 | Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ | March 2006 | November 2006 |
| NCT00000815 | Completed | Phase 2 | A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group | August 2001 | |
| NCT00388440 | Completed | Phase 4 | Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. | November 2000 | April 2001 |
| NCT00402831 | Completed | Phase 3 | ProQuad® Intramuscular vs Subcutaneous | October 6, 2006 | May 11, 2007 |
| NCT00406211 | Completed | Phase 3 | Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine | July 2004 | December 2004 |
| NCT00422292 | Completed | Phase 3 | Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers | December 2006 | April 2009 |
| NCT00432042 | Completed | Phase 3 | Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) | January 12, 2007 | March 27, 2008 |
| NCT00432523 | Completed | Phase 3 | Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011) | January 20, 2005 | September 5, 2005 |
| NCT00432731 | Completed | Phase 4 | Safety Study of a Refrigerator-stable Formulation of VARIVAX® | December 2004 | September 2005 |
| NCT00483574 | Completed | Phase 3 | Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers | May 2007 | April 2009 |
| NCT00510679 | Completed | N/A | Study of Post-Training Supports for Health Workers in Benin | July 1999 | October 2004 |
| NCT00560755 | Completed | Phase 3 | Safety Study of ProQuad® rHA in Infants (V221-037) | October 24, 2007 | November 24, 2008 |
| NCT00566527 | Completed | Phase 3 | Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) | November 29, 2007 | December 29, 2008 |
| NCT00578175 | Completed | Phase 2 | Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age | November 20, 2007 | March 17, 2009 |
| NCT00751348 | Completed | Phase 3 | Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 | October 1, 2008 | May 27, 2010 |
| NCT00861744 | Completed | Phase 2 | Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age | June 3, 2009 | June 18, 2012 |
| NCT00891007 | Completed | Phase 2 | Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years | June 2009 | August 2010 |
| NCT00892775 | Completed | Phase 2 | Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds | June 3, 2009 | December 13, 2010 |
| NCT00962819 | Completed | Measles, Mumps, and Rubella (MMR) Immunity in College Students | March 2010 | December 2012 | |
| NCT00969436 | Completed | Phase 3 | Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM | November 9, 2009 | February 21, 2011 |
| NCT00975507 | Completed | Phase 3 | ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) | March 1998 | June 1999 |
| NCT00984295 | Completed | Phase 3 | Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines | June 2000 | December 2001 |
| NCT00985153 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) | March 2000 | May 2001 |
| NCT00985166 | Completed | Phase 3 | A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) | August 2000 | May 2003 |
| NCT00986232 | Completed | Phase 2 | ProQuad Dose Selection Study (V221-011)(COMPLETED) | April 1999 | September 2000 |
| NCT01188343 | Completed | Phase 3 | Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers | August 2010 | December 2012 |
| NCT01346293 | Completed | Phase 3 | Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age | April 2011 | September 2013 |
| NCT01369394 | Completed | N/A | Making Decisions About the Measles-Mumps-Rubella Vaccine | June 2011 | July 2012 |
| NCT01506193 | Completed | Phase 3 | Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children | February 6, 2012 | March 31, 2014 |
| NCT01536405 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) | June 5, 2012 | January 27, 2014 |
| NCT05952505 | Not yet recruiting | Phase 4 | Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines | August 2023 | December 2024 |
| NCT05860920 | Not yet recruiting | Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal | July 2023 | June 2024 | |
| NCT05803538 | Not yet recruiting | N/A | Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial | May 15, 2023 | January 30, 2024 |
| NCT05771779 | Not yet recruiting | Phase 3 | Co-administration Study of OCV, TCV and MR | October 14, 2023 | May 2025 |
| NCT06456788 | Not yet recruiting | Barriers and Facilitators to MMR Vaccination Among Healthcare Workers | July 2024 | February 2025 | |
| NCT06218368 | Recruiting | N/A | A Tool Kit to Improve Vaccine Confidence in the Philippines | January 31, 2024 | February 25, 2025 |
| NCT06331702 | Recruiting | Phase 4 | Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) | March 2, 2024 | December 31, 2024 |
| NCT01770119 | Recruiting | Phase 4 | Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients | April 2013 | October 2025 |
| NCT05894395 | Recruiting | Phase 3 | Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination | December 1, 2023 | September 1, 2025 |
| NCT04899765 | Recruiting | Phase 4 | Measles and BCG Vaccines for Mother and Child | May 20, 2021 | December 31, 2027 |
| NCT00138255 | Terminated | Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines | June 2004 | June 2005 | |
| NCT00258726 | Terminated | Phase 1/Phase 2 | Immune Responses to Two Dose Varivax +/- MMR-II | October 2005 | July 2007 |
| NCT00839917 | Terminated | Phase 3 | A Study of ProQuad™ in Healthy Children in Korea (V221-023) | February 2008 | May 2008 |
| NCT02662595 | Unknown status | N/A | mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau | March 2016 | January 2018 |
| NCT00932269 | Unknown status | Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease | March 2007 | September 2011 | |
| NCT05279248 | Unknown status | Phase 4 | The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine | August 25, 2021 | June 20, 2023 |
| NCT00828022 | Unknown status | Phase 1/Phase 2 | Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer | March 2009 | |
| NCT03330171 | Unknown status | Phase 4 | Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine | April 10, 2017 | December 1, 2022 |
| NCT00645996 | Unknown status | N/A | The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants | March 2008 | October 2009 |
| NCT01602094 | Unknown status | Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors | July 2012 | March 2013 | |
| NCT02712203 | Unknown status | MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component. | July 2004 | December 2016 | |
| NCT02219061 | Unknown status | Early Waning of Maternal Measles and Meningitis C Antibodies | May 2014 | December 2014 | |
| NCT01738841 | Withdrawn | Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines | August 2013 | March 2016 |
- Disase is a (Disease Ontology)
- DOID:934
- Cross Reference ID (Disease Ontology)
- GARD:3434
- Cross Reference ID (Disease Ontology)
- ICD10CM:B05
- Cross Reference ID (Disease Ontology)
- ICD9CM:055
- Cross Reference ID (Disease Ontology)
- MESH:D008457
- Cross Reference ID (Disease Ontology)
- NCI:C96406
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154338006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0025007
- Exact Synonym (Disease Ontology)
- morbilli
- ICD10 preferred id (Insert disease from ICD10)
- D0000498
- ICD10 class code (Insert disease from ICD10)
- B05
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008457